China Isotope & Radiation Corporation (1763.HK)

11.100 -0.100 (-0.89%) At close: 04:08PM HKT

China Isotope & Radiation Corporation

No. 66 Changwa Middle Street
Haidian District
Beijing
China
86 10 6851 5220
https://www.circ.com.cn

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 3,105

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Junqi Zhang	Executive Chairman	382.86k	N/A	1972
Mr. Hongchao Xu	GM & Executive Director	1.12M	N/A	1971
Mr. Jin Du	Chief Engineer	1.19M	N/A	1966
Mr. Guomin Fan	Deputy GM & Executive Director	1.11M	N/A	1971
Mr. Youquan Gui	Chief Accountant, Chief Legal Officer and Joint Company Secretary	N/A	N/A	1975
Ms. Mei Ha Kam FCIS, FCS (PE)	Joint Company Secretary	N/A	N/A	1968

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; urea breath test kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment sells medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications; and sells radiation therapy equipment and other miscellaneous services. In addition, the company engages in the production and sale of bio-pharmaceuticals. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.

Corporate governance

China Isotope & Radiation Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.